Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

133 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
High-dose methotrexate with leucovorin rescue in ovarian cancer: a phase II study.
Parker LM, Griffiths CT, Yankee RA, Knapp RC, Canellos GP. Parker LM, et al. Cancer Treat Rep. 1979 Feb;63(2):275-9. Cancer Treat Rep. 1979. PMID: 312692
cis-Diamminedichloroplatinum(II) therapy for advanced ovarian cancer.
Pesando JM, Come SE, Stark J, Parker LM, Griffiths CT, Canellos GP. Pesando JM, et al. Among authors: parker lm. Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1147-8. Cancer Treat Rep. 1980. PMID: 7193089
Cryopreserved autologous marrow infusion following high dose cancer chemotherapy.
Tobias JS, Weiner RS, Giffiths CT, Richman CM, Parker LM, Yankee RA. Tobias JS, et al. Among authors: parker lm. Eur J Cancer. 1977 Mar 29;13(3):269-77. doi: 10.1016/0014-2964(77)90215-8. Eur J Cancer. 1977. PMID: 324770 No abstract available.
Intraaterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma: a clinical and pharmacology report.
Bern MM, McDermott W Jr, Cady B, Oberfield RA, Trey C, Clouse ME, Tullis JL, Parker LM. Bern MM, et al. Among authors: parker lm. Cancer. 1978 Aug;42(2):399-405. doi: 10.1002/1097-0142(197808)42:2<399::aid-cncr2820420204>;2-5. Cancer. 1978. PMID: 209882
Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma.
Parker LM, Griffiths CT, Yankee RA, Canellos GP, Gelman R, Knapp RC, Richman CM, Tobias JS, Weiner RS, Frei E 3rd. Parker LM, et al. Cancer. 1980 Aug 15;46(4):669-74. doi: 10.1002/1097-0142(19800815)46:4<669::aid-cncr2820460407>;2-p. Cancer. 1980. PMID: 7397632
Role of cytoreductive surgical treatment in the management of advanced ovarian cancer.
Griffiths CT, Parker LM, Fuller AF Jr. Griffiths CT, et al. Among authors: parker lm. Cancer Treat Rep. 1979 Feb;63(2):235-40. Cancer Treat Rep. 1979. PMID: 445502
Phase I trial of bruceantin.
Garnick MB, Blum RH, Canellos GP, Mayer RJ, Parker L, Skarin AT, Li FP, Henderson IC, Frei E 3rd. Garnick MB, et al. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1929-32. Cancer Treat Rep. 1979. PMID: 526926
Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.
Bast RC Jr, Berek JS, Obrist R, Griffiths CT, Berkowitz RS, Hacker NF, Parker L, Lagasse LD, Knapp RC. Bast RC Jr, et al. Cancer Res. 1983 Mar;43(3):1395-401. Cancer Res. 1983. PMID: 6825108
Primary radiation therapy for locally advanced breast cancer.
Sheldon T, Hayes DF, Cady B, Parker L, Osteen R, Silver B, Recht A, Come S, Henderson IC, Harris JR. Sheldon T, et al. Cancer. 1987 Sep 15;60(6):1219-25. doi: 10.1002/1097-0142(19870915)60:6<1219::aid-cncr2820600610>;2-2. Cancer. 1987. PMID: 3621108
N-trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studies.
Parker LM, Hirst M, Israel M. Parker LM, et al. Cancer Treat Rep. 1978 Jan;62(1):119-27. Cancer Treat Rep. 1978. PMID: 272230 No abstract available.
133 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page